BB Biotech’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$627M Sell
7,725,000
-1,016,334
-12% -$82.5M 15.76% 1
2018
Q4
$473M Buy
8,741,334
+75,000
+0.9% +$4.05M 15.14% 1
2018
Q3
$447M Hold
8,666,334
11.83% 1
2018
Q2
$361M Buy
8,666,334
+150,000
+2% +$6.25M 10.43% 1
2018
Q1
$375M Buy
8,516,334
+380,000
+5% +$16.8M 10.37% 1
2017
Q4
$409M Buy
8,136,334
+274,400
+3% +$13.8M 11.52% 1
2017
Q3
$399M Buy
7,861,934
+507,839
+7% +$25.7M 11.03% 3
2017
Q2
$374M Sell
7,354,095
-107,200
-1% -$5.45M 11.43% 3
2017
Q1
$300M Buy
7,461,295
+548,123
+8% +$22M 9.81% 3
2016
Q4
$331M Sell
6,913,172
-250,000
-3% -$12M 12.25% 3
2016
Q3
$262M Buy
7,163,172
+58,334
+0.8% +$2.14M 9.23% 3
2016
Q2
$165M Buy
7,104,838
+325,000
+5% +$7.57M 6.53% 4
2016
Q1
$275M Buy
6,779,838
+250,000
+4% +$10.1M 10.91% 3
2015
Q4
$404M Sell
6,529,838
-105,000
-2% -$6.5M 11.39% 3
2015
Q3
$268M Buy
6,634,838
+705,412
+12% +$28.5M 8.5% 5
2015
Q2
$341M Buy
5,929,426
+200,000
+3% +$11.5M 9.25% 3
2015
Q1
$365M Sell
5,729,426
-247,100
-4% -$15.7M 10.87% 2
2014
Q4
$369M Sell
5,976,526
-660,000
-10% -$40.7M 11.95% 2
2014
Q3
$258M Sell
6,636,526
-70,000
-1% -$2.72M 10.48% 3
2014
Q2
$231M Buy
6,706,526
+405,000
+6% +$14M 10.98% 4
2014
Q1
$272M Sell
6,301,526
-116,022
-2% -$5.01M 14.04% 2
2013
Q4
$256M Sell
6,417,548
-785,037
-11% -$31.3M 13.66% 3
2013
Q3
$270M Sell
7,202,585
-566,587
-7% -$21.3M 14.71% 2
2013
Q2
$209M Buy
+7,769,172
New +$209M 15.04% 2